Share on:
New study confirms the efficacy of Eprecis® 2% in lactating goats after a single subcutaneous administration at the labelled dose
Background information
The health and productivity of dairy goats continue to be impacted by gastrointestinal nematodes and lungworms. Eprinomectin is frequently selected for treatment because it is generally effective and does not require a milk withdrawal period. However, some factors, such as lactation, can have an impact on eprinomectin pharmacokinetics and potentially its efficacy.
How did they prove it?
A new study conducted conjointly by Moredun Scientific, Argenta Germany and Ceva confirms the efficacy of one subcutaneous administration of Eprecis® 2% in lactating goats to address common gastrointestinal nematodes and lungworms infection with the currently labelled dose of 0.1 ml of Eprecis® 2% for 10 kg of bodyweight.
You can read more about it here:
